FDA 483 - Verdure Sciences, Inc. - July 12, 2024

An FDA inspection of Verdure Sciences, Inc. in Noblesville, IN, revealed a significant regulatory lapse. The firm, acting as a sponsor, failed to submit an Investigational New Drug (IND) application to the FDA before initiating a clinical investigation. This indicates a serious non-compliance with regulations governing clinical trials and drug development.